+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Genders
ID05530304

Study of Outcomes Using a Triple Inner Branched Aortic Arch Stentgraft for Aortic Arch Conditions

Led by University Hospital Muenster · Updated on 2023-09-13

30

Participants Needed

1

Research Sites

12 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are monitoring the outcomes of using a triple inner branched aortic arch stentgraft in patients with aortic arch conditions such as aneurysms and dissections. This prospective, multicenter registry aims to collect new information about treatment planning and management for these aortic arch pathologies. The study observes patients treated with the triple inner branched arch stentgraft device from Terumo Aortic. The focus is on evaluating the procedures feasibility, including cannulation and stentgrafting of the three branches, as well as tracking complications during and after the intervention. Follow-up assessments continue for up to three years to monitor long-term outcomes. Participants will be followed closely with evaluations including mortality and stroke rates 30 days after the procedure and during the three-year follow-up period. Researchers will also assess morbidity, endoleaks, patency of the stented branches, and long-term survival. Patients will need to be available for follow-up visits and provide informed consent to participate in this observational study.

CONDITIONS

Brief Title

Outcome of a Triple Inner Branched Aortic Arch Stentgraft. A Prospective, Multicenter Registry.

Research Team

A

Alexander Oberhuber, MD, PhD

V

vascular trial unit

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here